Skip to main content
    T

    Twist Bioscience Corp (TWST)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $148.16
    -3.17 (-2.09%)

    Market Cap: $9.82B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(21/32)
    Avg Surprise
    -21.54%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.27
    Range$-0.81 - $0.66
    4 analysts
    Revenue Consensus
    $132M
    Range$132M - $133M
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.14
    Range$-0.31 - $-0.04
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.10-45.3%
    60d ago$-0.16+12.8%
    30d ago$-0.16+12.8%
    7d ago$-0.16+12.8%
    Current$-0.14
    Revenue Consensus
    $126M
    Range$124M - $128M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.14---
    Sep 26EST
    		-$0.27---
    Jun 26
    Reported Aug 3
    		$-0.56$-0.50-12.00%Miss-19.1%
    Mar 26
    Reported May 4
    		$-0.60$-0.53-13.21%Miss+9.1%
    Dec 25
    Reported Feb 2
    		$-0.50$-0.52+3.85%Beat+5.7%
    Sep 25
    Reported Nov 14
    		$-0.45$-0.50+10.00%Beat+23.7%
    Jun 25
    Reported Aug 4
    		$-0.47$-0.57+17.54%Beat+32.9%
    Mar 25
    Reported May 5
    		$-0.66$-0.56-17.86%Miss+16.5%
    Dec 24
    Reported Feb 3
    		$-0.53$-0.63+15.87%Beat+29.3%
    Sep 24
    Reported Nov 18
    		$-0.59$-0.69+14.49%Beat+21.3%
    Jun 24
    Reported Aug 2
    		$-0.70$-0.77+9.09%Beat+31.4%
    Mar 24
    Reported May 2
    		$-0.79$-0.81+2.47%Beat+25.5%
    Dec 23
    Reported Feb 2
    		$-0.75$-0.77+2.60%Beat+7.4%
    Sep 23
    Reported Nov 17
    		$-0.75$-0.86+12.79%Beat+25.7%
    Jun 23
    Reported Aug 4
    		$-1.02$-1.06+3.77%Beat+5.6%
    Mar 23
    Reported May 5
    		$-1.06$-1.10+3.64%Beat-3.9%
    Dec 22
    Reported Feb 3
    		$-0.81$-1.17+30.77%Beat+15.6%
    Sep 22
    Reported Nov 18
    		$-1.01$-1.13+10.62%Beat-20.2%
    Jun 22
    Reported Aug 5
    		$-1.08$-1.31+17.56%Beat-38.5%
    Mar 22
    Reported May 5
    		$-1.02$-1.30+21.54%Beat-30.8%
    Dec 21
    Reported Feb 4
    		$-0.96$-1.06+9.43%Beat-33.3%
    Sep 21
    Reported Nov 22
    		$-0.84$-0.79-6.33%Miss-55.6%
    Jun 21
    Reported Aug 6
    		$-0.78$-0.75-4.00%Miss-16.4%
    Mar 21
    Reported May 6
    		$-0.78$-0.78+0.00%Beat+8.2%
    Dec 20
    Reported Feb 4
    		$-0.72$-0.77+6.49%Beat+28.0%
    Sep 20
    Reported Nov 23
    		$-0.54$-0.70+22.86%Beat+43.7%
    Jun 20
    Reported Aug 6
    		$-0.67$-0.88+23.86%Beat+27.2%
    Mar 20
    Reported May 7
    		$-0.85$-0.75-13.33%Miss+8.6%
    Dec 19
    Reported Feb 6
    		$-1.00$-0.83-20.48%Miss+15.3%
    Sep 19
    Reported Dec 11
    		$-0.96$-0.83-15.66%Miss+85.4%
    Jun 19
    Reported Aug 1
    		$-0.92$-0.82-12.20%Miss-39.4%
    Mar 19
    Reported Apr 30
    		$-0.93$-0.97+4.12%Beat-
    Dec 18
    Reported Feb 7
    		$-1.18$-0.85-38.82%Miss-
    Sep 18
    Reported Nov 1
    		$-6.59$-0.75-778.67%Miss-
    Jun 18
    Reported Aug 29
    		$-0.66$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-70.22EV/EBITDAN/A
    Price/FCF-94.22xFCF Yield-1.06%
    Profitability
    Profit Margin-31.70%Operating Margin-30.60%
    ROE-29.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.67xQuick Ratio2.38x
    Trading Statistics
    Beta2.19Avg Volume3.15M
    52-Week High$219.7152-Week Low$23.30

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$166.75
    SMA 20$170.24
    SMA 50$146.85
    SMA 200$82.20
    EMA 10$160.71
    EMA 20$161.59
    EMA 50$146.15
    EMA 200$95.43

    MACD

    Line: 2.63Signal: 8.17Hist: -5.54

    ADX

    ADX: 28.2+DI: 23.8-DI: 22.3

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down4.0
    PSAR$201.15

    Bollinger Bands

    Upper Band$203.79
    Lower Band$136.70
    %B Position3941%(Upper)
    Band Width0.17

    RSI (14-Day)

    Neutral
    44.6

    Momentum Oscillators

    Stoch %K7.8
    Stoch %D11.3
    Williams %R-95.3
    ROC (10d)-23.3%
    Momentum-45.08
    CCI (20d)-97.6
    MFI (14d)35.4

    Volatility Measures

    ATR (14d)$14.21(9.6%)
    StdDev (20d)16.77
    Hist Vol113.1%(High)

    Volume Flow

    VWAP$149.65
    OBV20.0M
    AD Line15.7M
    CMF (20d)-0.094

    Volume Metrics

    Avg Vol (20d)3.3M
    Vol Ratio0.6x
    VWMA (20d)$169.94

    Pivot Points

    R3$163.27
    R2$158.75
    R1$155.04
    Pivot Point$150.52
    S1$146.81
    S2$142.29
    S3$138.58

    Advanced Oscillators

    TSI5.53
    Ultimate Osc31.8
    KST224.71

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$118.38M$110.72M$103.70M$99.01M$96.06M$92.79M$88.71M$84.71M$81.46M$75.30M$71.50M$66.95M
    Cost of Revenue$55.92M$53.59M$49.73M$48.17M$44.76M$46.77M$45.87M$46.48M$46.19M$44.42M$42.54M$42.42M
    Gross Profit$62.45M$57.12M$53.97M$50.84M$51.30M$46.03M$42.84M$38.23M$35.27M$30.88M$28.96M$24.52M
    Operating Expenses$98.73M$102.98M$86.87M$80.77M$81.42M$87.59M$77.48M$74.28M$124.19M$79.77M$75.94M$74.63M
    R&D$18.02M$19.70M$17.13M$17.01M$18.05M$23.92M$21.31M$21.14M$22.47M$24.15M$23.10M$23.75M
    SG&A$80.71M$76.08M$69.74M$63.76M$63.37M$63.67M$56.18M$53.14M$56.79M$55.62M$52.84M$47.39M
    Operating Income$-36,280,000$-45,863,000$-32,900,000$-29,935,000$-30,120,000$-41,560,000$-34,644,000$-36,043,000$-88,922,000$-48,889,000$-46,977,000$-50,111,000
    Interest Income$1.50M$1.71M$2.17M$2.63M$2.69M$2.80M$3.24M$3.62M$3.66M$3.94M$4.12M$3.89M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-34,740,000$-43,978,000$-30,254,000$-26,882,000$20.58M$-39,153,000$-31,497,000$-34,751,000$-85,380,000$-45,147,000$-42,888,000$-46,465,000
    Income Tax Expense$311,000$43,000$253,000$256,000$191,000$175,000$97,000$-96,000$191,000$345,000$120,000$-222,000
    Net Income$-35,051,000$-44,021,000$-30,507,000$-27,138,000$20.39M$-39,328,000$-31,594,000$-34,655,000$-85,571,000$-45,492,000$-43,008,000$-46,243,000
    EBITDA$-29,462,000$-39,274,000$-26,235,000$-23,678,000$23.96M$-35,550,000$-28,357,000$-31,715,000$-80,742,000$-40,784,000$-38,837,000$-41,862,000
    EBIT$-36,240,000$-45,688,000$-32,429,000$-29,682,000$17.89M$-41,954,000$-34,737,000$-38,371,000$-89,043,000$-49,088,000$-47,008,000$-50,362,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TWST

    Government Contracts

    Gov Obligations (TTM)
    $195366
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    112.9%
    Active Awards
    4
    New Awards (TTM)
    3
    Avg Remaining Term
    10.8 mo

    Top agency: Department of Justice at 47.3% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    15F06726P0000533Department of JusticeFederal Bureau of Investigation$97120Jun 29, 2026
    1232SA25P0166Department of AgricultureAgricultural Research Service$60861Aug 5, 2025
    36C26226P1118Department of Veterans AffairsDepartment of Veterans Affairs$47450Jun 30, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Technical Analysis of Twist Bioscience Corporation (CRYPTOCOM:TWSTUSD.P)

    This article provides a technical analysis overview for Twist Bioscience Corporation (TWSTUSD.P) on Crypto.com. It displays an indicators' summary for various timeframes, including moving averages and oscillators...

    TradingView•10/15/26•Neutral

    TD Cowen raises target for Twist Bioscience stock to USD 190.00

    TD Cowen has increased its price target for Twist Bioscience (TWST) stock to $190.00, up from $115.00, maintaining a Buy rating. This adjustment follows the company's fiscal third-quarter revenue of $118.38 million...

    ad-hoc-news.de•10/15/26•Bullish

    Price-Driven Insight from (TWST) for Rule-Based Strategy

    This article provides a price-driven analysis of Twist Bioscience Corporation (NASDAQ: TWST) for rule-based trading strategies. It highlights weak near and mid-term sentiment but a strong long-term outlook...

    Stock Traders Daily•10/14/26•Neutral

    Form 4 Twist Bioscience Corp: Adam Laponis (CFO) For: 9 October

    This article reports on a Form 4 filing for Twist Bioscience Corp (TWST) concerning its CFO, Adam Laponis, for October 9th. A Form 4 is a document filed with the SEC to disclose changes in beneficial ownership...

    Investing.com India•10/13/26•Neutral

    Form 4 Twist Bioscience Corp: Adam Laponis (CFO) For: 9 October

    This article reports on a Form 4 filing for Twist Bioscience Corp, indicating activity by its CFO, Adam Laponis...

    Investing.com Nigeria•10/13/26•Neutral

    TWST Valuation and Fair Value

    P/E
    -70.2x
    P/FCF
    -94.2x
    P/B
    20.7x
    See GNG's fair value

    TWST Profitability: Margins, ROIC and FCF

    Gross margin
    52.0%
    Operating margin
    -30.6%
    Net margin
    -31.7%
    ROE
    -29.6%
    FCF margin
    -22.7%
    FCF yield
    -1.1%

    TWST Competitors

    CompanyTicker
    The Ensign Group IncENSG
    Bio-Rad Laboratories IncBIO-B
    Apogee Therapeutics, Inc. Common StockAPGE
    Nuvalent IncNUVL
    Globus MedicalGMED
    Bio-Rad Laboratories IncBIO
    Align Technology IncALGN
    Krystal Biotech IncKRYS

    Sector: Healthcare

    TWST Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    7
    Hold
    3
    Sell
    1
    Strong Sell
    0

    TWST Bull Case vs Bear Case

    Bull case

    • TWST grew quarterly revenue 23.2% year over year.
    • 69.2% of TWST's analyst ratings are Buy or Strong Buy.

    Bear case

    • TWST has a -31.7% net profit margin.

    TWST Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    2.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.27

    Frequently Asked Questions About TWST

    Does TWST pay dividends?

    Twist Bioscience Corp (TWST) does not currently pay a regular dividend.

    What is TWST's market cap?

    Twist Bioscience Corp (TWST) has a market capitalization of $9.82B with a current stock price of $148.16.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In